This page contains brief information about copanlisib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s) Aliqopa
FDA Approved Yes
FDA label information for this drug is available at DailyMed.
Use in Cancer
Copanlisib hydrochloride is approved to treat:
- Follicular lymphoma that has relapsed. It is used in adults who have received at least two other systemic treatments.
Copanlisib hydrochloride is also being studied in the treatment of other types of cancer.
More About Copanlisib Hydrochloride
Definition from the TCH Drug Dictionary – Detailed scientific definition and other names for this drug.
